The Latest Breaking News from Merck

Nvidia continues to innovate AI GPUs and maintains a strong balance sheet, but hedge fund managers see several headwinds for the company in the coming months.

Japanese biochemist whose work on fungal extracts led to the creation of the first statin

While all eyes are still on standout AI tech stocks, these three dividend-paying Dow stocks are beating the broader market this year.

Merck & Company has significantly outperformed the Dow Jones recently, and Wall Street analysts expect further gains for the stock.

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

Breakthrough treatments hold promise for patients and investors.

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

The pharmaceutical industry is expected to expand significantly due to the ever-rising global medical needs and technological advances. In this scenario, let’s analyze the better investment option between popular pharma stocks, Merck &Co (MRK) and AbbVie (ABBV).

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

European shares rise, S&P 500 hits record high, dollar strengthens, Asian markets mixed. Market anticipates U.S. government's update on consumer spending a...